EFEThe Hague

The European Medicines Agency on Tuesday began a rolling review of the first vaccine submitted for EU market authorization by a Chinese company.

The EU regulator’s human medicines committee (CHMP) will base the review of Sinovac’s COVID-19 Vaccine (Vero Cell) Inactivated on preliminary results from laboratory and clinical studies. EFE